Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

On-line 3-dimensional Optical Frequency Domain Imaging to Optimize Bifurcation Stenting Using UltiMaster Stent: OPTIMUM Study

NCT02972489 is registered in ClinicalTrials.gov with Increase Co., Ltd. as lead sponsor.

NCT NCT02972489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
On-line 3-dimensional Optical Frequency Domain Imaging to Optimize Bifurcation Stenting Using UltiMaster Stent: OPTIMUM Study
Lead sponsor
Increase Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2017
Enrollment
106 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bifurcation lesion, coronary artery disease